Metoprolol (generic), Toprol XL Wire
Comprehensive News Feed for Metoprolol (generic), Toprol XL.
Results 1 - 20 of 48 in Metoprolol (generic), Toprol XL
-
Not All Drugs Are the Same After All
Because of possible variations among generic drugs, Dr. James Reiffel, a cardiologist, is leery of prescribing them for some cases. Comment?
-
Generic Drugs not All the Same After All
w/Photo
Let me start by saying I'm a fan of generic drugs. They save Americans billions of dollars each year and give us access to wonderful drugs at affordable prices. Comment?
-
Not All Drugs Are the Same After All
Because of possible variations among generic drugs, Dr. James Reiffel, a cardiologist, is leery of prescribing them for some cases. Comment?
-
In North Carolina, you may be at risk of arrest and conviction of Driving While Impaired if you routinely take certain prescription medications. Comment?
-
Sandoz launches hypertension generic
PRINCETON,A N.J. Sandoz has launched an authorized generic version of a hypertension drug, the generic drug maker announced Wednesday. Comment?
-
What Are Beta-Blockers? What Are Beta-Blockers For?
Editor's Choice Main Category: Heart Disease Also Included In: Cardiovascular / Cardiology ; Hypertension Article Date: 04 Dec 2009 - 0:00 PST Beta-blockers , also known as beta-adrenergic blocking agents , beta-adrenergic antagonists , or beta antagonists , are a type of drug that block the action of the sympathetic nervous system of the heart, ... Comment?
-
What Are Beta-Blockers? What Are Beta-Blockers For?
Beta-blockers , also known as beta-adrenergic blocking agents , beta-adrenergic antagonists , or beta antagonists , are a type of drug that block the action of the sympathetic nervous system of the heart, resulting in a relief of stress on the heart. Comment?
-
Build Your Fortune With These Winners
The Oracle of Omaha, Warren Buffett, turned an initial bankroll of $10,000 into a multibillion-dollar conglomerate.A Shelby Davis began with $50,000, and he amassed a $900 million fortune. Comment?
-
I'm innocent, pharmacist tells stolen pills trial
A pharmacist from Huddersfield allegedly recruited by a gang to help sell millions of stolen tablets has told a jury he is innocent. Comment?
-
3 Stocks With 25% Sales Growth
Last quarter, the median S&P 500 company reported a 9% drop in sales versus a year earlier, but more companies beat Wall Street's sales forecasts than missed them. Comment?
-
Pharmacist 'helped gang sell stolen tablets'
A pharmacist from Huddersfield was recruited by a gang to help sell millions of stolen tablets, a court heard. Comment?
-
New product launches, limited competition helped boost Par's Q3
WOODCLIFF LAKE, N.J. Generic drug maker Par Pharmaceutical had revenues of $294.8 million and profits of $26.3 million during third quarter 2009, the company announced in a financial report Friday. Comment?
-
New product launches, limited competition helped boost Par's Q3
WOODCLIFF LAKE, N.J. Generic drug maker Par Pharmaceutical had revenues of $294.8 million and profits of $26.3 million during third quarter 2009, the company announced in a financial report Friday. Comment?
-
Par 3Q profit surges on product sales
w/Photo
Generic drugmaker Par Pharmaceutical Companies Inc. said Friday its profit surged in the third quarter on a boost in product sales. Comment?
-
Watson Pharma Beats by a Penny
Watson Pharmaceuticals, Inc. reported third quarter earnings of 66 cents per share, a cent above the Zacks Consensus Estimate. Comment?
-
AstraZeneca boosts gains on swine flu vaccine sales
LONDON: AstraZeneca increased its full-year outlook for the second quarter in a row yesterday as earnings jumped 28 percent, beating forecasts, helped by earlier-than-expected revenues from its swine flu vaccine. Comment?
-
AstraZeneca reports jump in Q3 profit
LONDON Profits for AstraZeneca were up by 27% for third quarter 2009 compared with third quarter 2008, the Anglo-Swedish drug maker announced in an earnings report Thursday. Comment?
-
AstraZeneca sparkling set of results flatter to deceive
Competition from generics is like to be bitter pill for AstraZeneca investors, while insurer Standard Life optimistically prepares for the arrival of new boss David Nish. Comment?
-
Tempus: Concern over expiring patents takes the shine off AstraZeneca
David Brennan, the chief executive of AstraZeneca, was upbeat yesterday as he unveiled a 27 per cent jump in pre-tax profit for the third quarter - better than expected - and increased his forecast for the year. Comment?
-
AstraZeneca PLC Third Quarter & Nine Months Results 2009
LONDON, Oct. 29. 2009-- Strong business performance has been driven by good operating execution bolstered by revenue upsides from Toprol-XL and H1N1 vaccine sales. Comment?
Metoprolol (generic), Toprol XL Forum
Most Popular
- U.S. Democrats secure 60th vote on health bill - 358 comments
- DC Mom Files Complaint Against Lesbian Teacher for Corrupting Child's Innocence - 159 comments
- Aide quits Paul's Senate campaign after blog post - 211 comments
- The 3 Michigan Churches Who Are Quitting the Homeless Because Another Church ... - 146 comments
- Zizie Ezette & Bung Mokhtar Dikatakan Berkahwin Tapi Bung Nafi - 106 comments
- 1 Year Later-Obama's Legacy of Lies and Broken Promises - 94 comments
- Evangelical church opens doors fully to gays ... - 138 comments
- Workers strike at Barbourville manufacturer - 69 comments
- HERE WE GO AGAIN, CLOSE THE BOGIE DOWN? FIGHTS AND STABBINGS AGAIN - 38 comments
- Exclusive: Nelson Explains Stance On Health Care - 68 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
